Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Updated the study page by expanding the Locations section with additional site entries (Arizona, California, Colorado, Florida, Georgia, Illinois, Iowa, Kentucky, Maryland, Michigan, Missouri, Nebraska, New York, North Carolina, Ohio, Tennessee, Utah, Washington, and New Brunswick) and updating the revision to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T20:56:34.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Publications From PubMed section wording was updated to indicate automatic filling from PubMed. Revision labels were updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T10:33:16.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page no longer displays the government funding/operational status notice; core study content and details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T06:51:14.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The location entry changed from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' in the study's Locations list. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-11T02:12:19.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The study details content appears unchanged between versions; there are no additions or deletions to arms, criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:41:48.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and the new government-operating-status notice; the old v3.1.0 tag was removed.
    Difference
    2%
    Check dated 2025-10-06T05:09:52.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.